83
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Evidencing the Modulation of P-glycoprotein at Blood-Ocular Barriers using Gamma Scintigraphy

, , , , &
Pages 73-77 | Received 15 Jul 2008, Accepted 17 Oct 2008, Published online: 02 Jul 2009

REFERENCES

  • Cunha-Vaz J. The blood-ocular barriers. Surv Ophthalmol 1979; 23: 279–286
  • Duvvuri S, Majumdar S, Mitra A K. Drug delivery to the retina: Challenges and opportunities. Expert Opin Biol Ther 2003; 3: 45–56
  • Senthilkumari S, Velpandian T, Biswas N R, Sonali N, Ghose S. Evaluation of the impact of P-glycoprotein (P-gp) drug efflux transporter blockade on the systemic and ocular disposition of P-gp substrate. J Ocul Pharmacol Ther 2007; 24: 290–300
  • Senthilkumari S, Velpandian T, Biswas N R, Saxena R, Ghose S. Evaluation of the modulation of P-glycoprotein (P-gp) on the intraocular disposition of its substrate in rabbits. Curr Eye Res 2008; 33: 333–343
  • Piwnica-Worms D, Chi A ML, Budding M, Kronauge J F, Kramer R A, Croop J M. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Rev 1993; 53: 1–8
  • Ballinger J, Hua H, Berry B, Firby P. Boxen 1. Technetium-99m-sestamibi as an agent for imaging P-glycoprotein-mediated multidrug resistance: In vitro and in vivo studies in a rat breast tumor cell line and its doxorubicin-resistant variant. Nucl Med Commun 1995; 16: 253–257
  • Ambudkar S V, Dey S, Hryeyna C A, Ramachandra M, Pastan I, Gottesman M M. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 1999; 39: 361–398
  • Wackers F J, Berman D, Maddahi J, Waston D D, Beller G A, Strauss H W, et al. Technetium-99m-hexakis 2-methoxy isobutlisonitrile: Human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 1989; 30: 301–309
  • Bambeke F V, Michot J M, Tulkens P M. Antibiotic efflux pumps in eukaryotic cells: Occurrence and impact on antibiotic cellular pharmacokinetics, pharmaodynamics, and toxicodynamics. J Antimicro Chemo 2003; 51: 1067–1077

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.